Business Description
Century Therapeutics is a Philadelphia-based biotechnology company founded in 2018 that develops off-the-shelf cell therapies to treat blood cancers, solid tumors, and autoimmune diseases. Its pipeline includes several advanced cell therapy candidates, most notably a beta cell replacement therapy for type 1 diabetes and two engineered immune cell therapies targeting B-cell-driven autoimmune conditions. All of its programs are built on a shared technology platform designed to help transplanted cells avoid rejection by the patient's immune system.
